Considerations on Subgroup Analyses in Clinical Trials
- PMID: 28431664
- DOI: 10.1016/j.ad.2017.03.003
Considerations on Subgroup Analyses in Clinical Trials
Comment on
-
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis: Subgroup analysis of Latin American patients in the phase 3 randomized UNCOVER-3 study.Actas Dermosifiliogr. 2017 Jul-Aug;108(6):550-563. doi: 10.1016/j.ad.2017.02.005. Epub 2017 Mar 23. Actas Dermosifiliogr. 2017. PMID: 28342534 Clinical Trial. English, Spanish.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
